Ocrelizumab gains positive CHMP opinion for RRMS and PPMS

Discuss Ocrelizumab, a monoclonal antibody treatment for MS.

Ocrelizumab gains positive CHMP opinion for RRMS and PPMS

Postby MSUK » Fri Nov 10, 2017 6:26 am

Roche, the makers of ocrelizumab have today announced that the Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion for the use of ocrelizumab in adults with active relapsing remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS)...Read more - http://www.ms-uk.org/ocrelizumab-gains-positive-chmp-opinion-rrms-and-ppms

Image
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2876
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Ocrevus (Ocrelizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service